Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Carespan Health Inc V.CSPN

CareSpan Health, Inc., together with its subsidiaries, operates as a healthcare technology and services company in the United States. The company offers CareSpan Clinic, a clinic-in-the-cloud workflow-driven platform that integrates remote patient monitoring, diagnostic tools, patient electronic health records, care collaboration capabilities, patient engagement, e-prescribing, and lab ordering, as well as deliver primary and urgent care, and behavioral health care. It also engages in technology development and licensing activities; and provides management services. The company is headquartered in New York, New York.


TSXV:CSPN - Post by User

Post by vanbmtzon Jun 07, 2022 1:27pm
331 Views
Post# 34737588

May30 PR - CARESPAN ACHIEVES 60% REVENUE GROWTH IN Q1/22

May30 PR - CARESPAN ACHIEVES 60% REVENUE GROWTH IN Q1/22

https://www.carespanhealth.com/carespan-achieves-60-revenue-growth-and-record-revenues-in-q1-22-with-its-continued-focus-on-enabling-nurse-practitioners-with-digital-care-technology/

  • Revenues of US$1.765 million for Q1-2022 compared to US$1.105 million for Q1-2021 an increase of 60% that was primarily driven by an 80% jump in patient visits.
  • The number of providers in our networks more than doubled to 103 practitioners as of March 30, 2022 , from 50 compared to a year ago.
  • Continued to manage the cost structure, operating loss was reduced to US$(0.671) million in Q1 2022 from US$(2.022) million in Q1 2021.
  • Focused on the implementation of the Remote Patient Monitoring (“RPM”) program that launched in March 2022 as a value-added service, and is targeting to enroll approximately 2,000 patients within its current patient base, for whom RPM would be a key component of their respective plan to manage chronic illness. The anticipated reimbursement under RPM is in the range of US$100 to US$115 per patient per month.
<< Previous
Bullboard Posts
Next >>